ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,222.68
0.16%
US Tech 100
17,650.00
0.05%
다우존스 지수
39,512.84
0.32%
Bitcoin
61,043.91
0.40%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. AMEX
  6. Matinas Biopharma Holdings Inc (MTNB)

  7. Matinas Biopharma Holdings Inc (MTNB) 뉴스

MTNB Matinas Biopharma Holdings Inc

0.1756
-0.0011 (-0.62%)
11 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Matinas Biopharma Holdings Inc MTNB AMEX 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.0011 -0.62% 0.1756 09:00:00
개장가 저가 고가 종가 전일 종가
0.1767 0.1673 0.177 0.1756 0.1767
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
10/05/202405:06EDGAR2Form 8-K - Current report
10/05/202405:05GLOBEMatinas BioPharma Reports First Quarter 2024 Financial..
10/05/202405:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/05/202421:00GLOBEMatinas BioPharma’s LNC Platform for the Delivery of Small..
02/05/202420:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss..
30/04/202421:00GLOBEIn Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in..
03/04/202421:30GLOBEMatinas BioPharma Prices $10 Million Registered Direct..
28/03/202405:05GLOBEMatinas BioPharma Reports 2023 Financial Results and..
25/03/202421:00GLOBEMatinas BioPharma Announces Positive in vivo Safety Data..
22/03/202422:15GLOBEThree Patients with Invasive Fusarium Infection in Matinas..
22/03/202419:30GLOBEMatinas BioPharma Regains Compliance with NYSE American..
26/02/202422:05EDGAR2Form 8-K - Current report
26/02/202422:00GLOBEMatinas BioPharma Provides Positive Outcomes Update on the..
20/02/202421:35EDGAR2Form 8-K - Current report
20/02/202421:30GLOBEMatinas BioPharma Successfully Reaches Agreement with FDA..
09/01/202421:30EDGAR2Form 8-K - Current report
03/01/202421:00GLOBEMatinas BioPharma to Present at Biotech Showcase 2024
27/12/202321:40EDGAR2Form 8-K - Current report
27/12/202321:30GLOBEMatinas BioPharma Demonstrates in vivo Biological Activity..
21/12/202321:40EDGAR2Form 8-K - Current report
21/12/202321:30GLOBEMatinas BioPharma Provides Update to MAT2203 Regulatory and..
16/12/202311:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202311:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202311:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202311:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202311:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202311:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202321:30EDGAR2Form 8-K - Current report
10/11/202307:25EDGAR2Form 8-K - Current report
09/11/202306:06EDGAR2Form 8-K - Current report
09/11/202306:05GLOBEMatinas BioPharma Reports Third Quarter 2023 Financial..
09/11/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:30GLOBEMatinas BioPharma Announces Positive in vivo Efficacy..
04/11/202305:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202306:20EDGAR2Form 8-K - Current report
01/11/202320:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss..
11/10/202323:25APSBiotech Catches Massive Premarket Bid
11/10/202320:30GLOBEPatient with Candida krusei Infection in Matinas BioPharma’s..
28/09/202320:00GLOBEMatinas BioPharma to Present at Two Investment Conferences..
27/09/202320:00GLOBEMatinas BioPharma to Feature MAT2203 in a Pipeline..
23/09/202306:25EDGAR2Form 8-K - Current report
23/09/202306:25GLOBEMatinas BioPharma Announces Notification of NYSE American..
21/09/202322:35GLOBEDawson James Securities Announces October Date for 8th..
20/09/202320:30EDGAR2Form 8-K - Current report
20/09/202306:25EDGAR2Form DEF 14A - Other definitive proxy statements
09/09/202306:15EDGAR2Form PRE 14A - Other preliminary proxy statements
06/09/202320:00GLOBEMatinas BioPharma to Participate in the H.C. Wainwright..
22/08/202320:30GLOBEMatinas BioPharma Announces Publication of Results from the..
10/08/202305:06EDGAR2Form 8-K - Current report
10/08/202305:05GLOBEMatinas BioPharma Reports Second Quarter 2023 Financial..

최근 히스토리

AMEX
MTNB
Matinas Biopharma
COIN
AFROUSD
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유